Clinical trial
"Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in…
NCT00377975 · Pennington Biomedical Research Center, Other · Completed
Key facts
| NCT number | NCT00377975 |
|---|---|
| Title | "Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous Fat |
| Official title | Synergistic Induction of UCP-1 by Ephedrine/Caffeine and Pioglitazone: A Rationale for Combination Therapy of Obesity |
| Lead sponsor | Pennington Biomedical Research Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | Ephedrine, Pioglitazone, Caffeine |
| Enrollment | 96 |
| Start date | Jan 1, 2003 |
| Completion | Nov 1, 2004 |
| First posted | Sep 19, 2006 |
| Last update posted | Jan 25, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: